Thermo Fisher Scientific: Garret Hampton

Garret Hampton has been appointed as president of the clinical next-generation sequencing and oncology business at Thermo Fisher Scientific. He joins the firm from Illumina, where he was senior VP of clinical genomics. Before that, he was VP and global head of oncology biomarker development and companion diagnostics at Genentech. Hampton holds a PhD in cancer genetics from the University of London and an undergraduate degree in natural sciences from Trinity College Dublin.